BioSpace News Archive

The global antibody production market size is expected to reach USD 37.81 Billion in 2030 and register a revenue CAGR of 14.4% during the forecast period.

Escient Pharmaceuticals, a clinical-stage company advancing novel small molecule therapeutics for the potential treatment of a broad range of neurosensory-inflammatory disorders, today announced the initiation of a Phase 2 clinical study of EP547 in subjects with cholestatic pruritus.

Scribe Therapeutics Inc., a molecular engineering company pioneering a CRISPR by Design™ platform for genetic medicine, announced it will participate in four upcoming conferences.

March of Dimes, the nation’s leading nonprofit fighting for the health of all moms and babies, announced the appointment of Dr. Elizabeth Cherot, as Senior Vice President and Chief Medical and Health Officer effective January 9, 2023.

Qualis Innovations Inc. currently trades under symbol “QLIS”, recently announced its financial 10-Q report on November 14, 2022.

ERS Genomics Limited is pleased to announce ATLATL Innovation Centre as its non-exclusive agent for licensing ERS’ intellectual property for commercial and/or research use in China.

InSitu Biologics, Inc. will share the latest investigational work on its multi-phase drug delivery matrix at the upcoming 21st Annual Pain Medicine Meeting of the American Society of Regional Anesthesia on November 18th , 2022.

Dr. Daniel Alexander one of the most respected and accomplished orthopedic surgeons in upstate New York has been named Chief Administrative Officer at ACH.

Varian, a Siemens Healthineers company, announced today that the first trial participant has been treated as part of GENESIS II (Genicular artEry embolisatioN in patiEnts with oSteoarthrItiS of the knee), a study of Embozene® microspheres for genicular artery embolization (GAE) as treatment of mild to moderate knee osteoarthritis.

Cellply Srl announced Alessia Zanelli, Board Member since 2021, has been appointed on October 13, 2022 as the new Chair of the Board to support the management team with near term strategic and commercial goals.